GBE did not modify cell morphology but decreased reactive oxygen species (ROS) levels. by Virginie Rhein (243241)

“…<b>D</b>) ROS levels (DHR fluorescence units/1×10⁵ cells normalized to the respective untreated control and APP cells = 100%) were significantly decreased after treatment with GBE (100 µg/ml; 24 h). …”

Retinoic acid improved cell morphology and decreased the number of hypertrophic cells in LT cultures. by Carmen Retana (479628)

“…<p>(<b>A</b>) Omentum-derived mesothelial cells (control) and effluent-derived mesothelial cells from LT and HT grown until confluence in the presence of ATRA (0, 50, 100 and 200 nM). …”

<i>Cadm1</i> KO mice exhibit decreased bone mineral density. by Shinya Nakamura (97647)

Casein kinase 1.2 depletion decreases ZC3H11 phosphorylation. by Igor Minia (399074)

“…</b> CK1.2 depletion causes a decrease in phosphorylated ZC3H11. RNAi was induced for 2 days, then the cells were transferred to either 37°C or 41°C for 1 hour. …”

Absence of LFA-1 results in decreased numbers of NKT cells within the regenerating liver. by Ann-Kathrin Jörger (3559358)

Knockdown of CoREST1 decreased tumor cell-mediated macrophage migration and activation. by Sohini Mazumdar (707540)

Down-regulation of <i>T. gondii</i> P-gp correlates with decreased lipid synthesis. by Iveta Bottova (250537)

Troglitazone decreases α5 integrin-dependent cell adhesion in K562 cells. by Amanda M. Hanson (543116)

Intracellular CAB2 undergoes filamentation with concurrent decreased survival in the absence of VopL. by Marcela de Souza Santos (4167772)

Insulin stimulation decreases the binding of Synip WT and ΔWW to syntaxin 4 in vitro. by Tsugumichi Saito (312859)

SIS3 decreases phosphorylation of CRMP2 without activating GSK-3β. by Kye-Im Jeon (441227)

<i>Plac8</i> knockdown in 3T3-L1 decreases adipogenesis. by Maria Jimenez-Preitner (120942)

Mylipb decreases tbk1-mediated irf3 phosphorylation and cellular antiviral response. by Zhi Li (72309)

“…<p>(A) Overexpression of <i>mylipb</i>-WT and <i>mylipb</i>-C381S inhibits tbk1-mediated phosphorylation of irf3. …”

Epithelial-specific disruption of <i>Meis1</i> decreased epidermal stem cells. by Kazuhiro Okumura (566659)

K-fold cross validation accuracy of different models. by Shayla Naznin (13014015)

Subjects:

Representative follicle types, H&E stain, 100X total magnification. by Anna H. Le (621100)

(a) Mycelial diameter (mm) determination on PDA plates, (b) Inhibition diameters, and (c) inhibition percentages of <i>Aspergillus flavus</i> treated with <i>U. epigea</i> extract... by Martha Cebile Jobe (21175426)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

The number of individuals sampled and the associated decrease in uncertainty when measuring 100 more individuals. by Tiago Veiga-Malta (5435726)

Distribution of miRs with a greater than two fold-change. by Stephanie L. Samani (17896610)

Subjects: